INTRODUCTION
Asthma is a widespread chronic disease. The National Center for Health Statistics estimates the prevalence of asthma in the United States to be 75 in 1,000 for non-Hispanic white adults, 86 in 1,000 for non-Hispanic blacks, and 59 in 1,000 for Hispanics. 1 Rates are higher for females (83 in 1,000) than for males (64 in 1,000). Moreover, asthma affects the quality of life of affl icted patients. [2] [3] [4] In 1998, to foster improvement in the care of patients with chronic illnesses, the Robert Wood Johnson Foundation initiated a national program called Improving Chronic Illness Care (ICIC), which is based in Seattle, Wash, at the MacColl Institute for Healthcare Innovation at Group Health Cooperative. Researchers involved in this program had developed the Chronic Care Model based on their experience and the clinical literature 5, 6 (http://www.improvingchroniccare.org).
In 1998, ICIC joined with the Institute for Healthcare Improvement to offer a Breakthrough Series (BTS) 7 Collaborative, using the Chronic Care Model as its foundation, the BTS Collaborative brought together organizations hoping to improve care for their asthma patients. Institute for Healthcare Improvement BTS Collaboratives promote a method for inducing and sustaining organizational change based on an explicit agreement on improvement goals, monitoring ongoing progress through specifi c measures, developing change ideas for the participating teams based on best practices, and the plan-do-study-act approach as a framework for monitoring and implementing continuous quality improvement. This study represents the fi rst evaluation of a BTS Collaborative for asthma. Its purpose is to evaluate whether the BTS Collaborative improved processes and outcomes of care for adult patients receiving asthma care at sites participating in the collaborative. Cretin et al give more details on the Chronic Care Model, the ICIC collaboratives, and our evaluation. 8 
METHODS
The BTS Collaborative for asthma began on February 1, 2000, and ended on March 1, 2001 . Twenty-six health care organizations volunteered to participate in the collaborative and paid a fee to attend. All asthma organizations were invited to participate in the RAND evaluation before the start of the collaborative. Six of these organizations agreed to participate in the RAND evaluation discussed here. These 6 organizations include rural and urban sites in the Northwest, East, and Puerto Rico. Three of the 6 organizations provided a control site for comparison. The control sites were always at locations physically separate from the intervention sites. The sites included rural and urban sites in the Northwest, West, and East. Four of the 6 BTS intervention sites (BTS sites) and 2 of the 3 control sites were Bureau of Primary Healthcare community health care centers. These clinics primarily serve patients of low socioeconomic status without access to private sector health care services. The remaining sites primarily served privately insured patients. Within each site all eligible patients were chosen for participation in the RAND evaluation.
Each intervention site sent a team to 3, 2-day learning sessions taught by BTS faculty. Most teams had 3 or 4 members, though a few were larger. The learning sessions were followed by 2-to 6-month action periods. We evaluated the infl uence of the collaborative on process of care and outcomes for the patients based on 2 data sources: a patient survey and medical records.
Survey Data Collection
Participating clinical organizations created an asthma patient registry based on medical record review. To be entered on a clinic' s asthma registry, patients had to have an encounter for asthma care during the 12 months prior to when the organization began participating in the collaborative. The internal control sites selected by the organizations participating in the RAND study also created asthma patient registries. All sites (both control and intervention) participating in the RAND study attempted to obtain consent from all patients on their asthma registries to release the contact information and diagnosis to the RAND survey research group. The RAND survey research group telephoned each consenting patient, confi rmed that the patient had asthma, and conducted a 30-minute interview about the patient' s asthma. The telephone interviews began shortly after the conclusion of the BTS Collaborative on March 13, 2001 , and were completed on December 31, 2001. The survey questions were offered in English, Spanish, and Mandarin. The English version of the survey instrument for this evaluation study is available at: http://www.rand.org/health/ICICE. The research effort was approved by local institutional review board (IRB) for each participating site as well as the RAND IRB.
Medical Records Data Collection and Scoring
In each telephone interview, eligible respondentseven those who refused to participate in the surveywere asked whether they would allow their medical record to be examined for this study. Upon gaining permission, a RAND-trained abstractor abstracted the patient' s outpatient medical record on site. The abstractors were not told whether the clinic was an intervention or control site. We examined care received during the 12 months before the BTS intervention and care received between the 4th and the 15th month after the BTS intervention started (March 1, 1999, to June 30, 2001 ). The 3-month delay was chosen in advance to allow the sites time to begin making changes. 8 The computer-based abstraction tool was developed for this study by a team that included experts in asthma care, in computer-based medical record abstraction tool development, and in quality-of-care measurement. This abstraction tool includes 11 quality indicators for asthma care, 9 of which had adequate variation for meaningful analysis. The indicators were based on the 1997 National Heart Lung Blood Institute guideline for asthma care 9 and the RAND Quality Assessment Tool. 10 For example, each participant' s medical record was scored on the following quality indicator: "All patients should have a written action plan in the medical record that is based on changes in symptoms or peak fl ow measurements." All participants would be eligible to receive a score of pass (1) or fail (0) on this indicator. A summary process-of-care score for each patient can also be assessed as the ratio of the number of indicators for which the patient is eligible ASTHMA QUALITY IMPROVEMENT COLLABORATIVE (denominator) to the number of times they received the indicated care (numerator).
Measurement

Survey-Based Variables of Process of Care
We measured 4 aspects of patient self-management: peak fl ow monitoring ("Do you check your peak fl ows at home?"), goal setting ("Did you work with one of your asthma doctors or nurses to set personal goals for your asthma treatment?"), presence of a written action plan ("Have your asthma doctors or nurses worked with you to develop an asthma action plan so that you know how to take care of your asthma?" "Do you have a copy of this plan in writing?"), and whether the patient had attended asthma education sessions ("In the past 6 months, did you attend any group classes to learn more about asthma?").
Asthma knowledge was assessed by 10 questions adapted from the National Asthma Education Program asthma knowledge questionnaire. 9 The knowledge variable counts the number of right answers to the 10 knowledge questions.
Patients were asked at the time of the telephone interview whether they were currently using a longterm asthma-control medication, such as cromolyn or inhaled steroids. If they responded yes, they were asked the name of the inhaler. If they did not know the name, they were asked the color of the inhaler canister, and that color was matched by the interviewer to a predetermined list of canister colors of long-term asthma inhaler medications. If the patient named a long-term asthma inhaler medication or named a canister color that matched the color of one of these inhalers, the patient was coded as currently using a long-term asthma-control medication.
Survey-Based Outcome Variables
We used the physical health summary scale from the SF-12 Health Survey 11 to assess generic health-related quality of life (HRQoL) and an adapted version of the Marks' Asthma Quality of Life questionnaire 12 to assess asthma-specifi c HRQoL. The Marks quality-of-life scale ranges from 0 to 10. Higher numbers refer to a greater impact of asthma on one' s life (ie, higher scores indicate worse quality of life).
To assess satisfaction with communication in care, we adapted 4 items from the provider communication composite of the Consumer Assessment of Health Plans asking about satisfaction with various aspects of communication in the previous 6 months, and we calculated an overall score as the mean of the 4 items (score range: 0 to 3, higher scores indicate greater satisfaction). 13 Acute care service use was measured by summing the total number of visits to an emergency department for asthma and the total number of admissions to the hospital lasting 1 or more night(s) during the previous 6 months. We used the term acute to distinguish this care of service use from planned ambulatory care follow-up visits, which theoretically should prevent acute care service use.
We measured lost productivity as the number of days the patient' s health kept him or her in bed in the previous month.
Covariates
All models that relate the intervention to key outcomes were adjusted for asthma severity, the number of comorbidities, education, annual income, insurance type, race or ethnicity, age, and sex.
We controlled for 3 levels of asthma severity: mild intermittent asthma, mild persistent asthma, and moderate or severe persistent asthma. Asthma severity categories were constructed based on guidelines from the National Heart Lung Blood Institute. 9 Patients were categorized as having mild intermittent asthma if they experienced asthma symptoms between 0 and 2 days per week and if they experienced asthma symptoms between 0 and 2 nights per month. Patients were categorized as having mild persistent asthma if they experienced asthma symptoms between 3 to 6 days per week or if they experienced asthma symptoms between 3 to 4 nights per month. Patients with daily asthma symptoms or with asthma symptoms on 5 nights per month or more were categorized as having moderate to severe persistent asthma. 9 We asked the patients whether they had any of the following comorbidities: hypertension, diabetes, chronic lung disease other than asthma, or peptic ulcer disease, or whether they ever had a heart attack, heart failure, or depression.
Survey Data: Imputations
To retain observations with 1 or 2 missing values, we imputed those values by grouping observations into up to 16 different categories based on demographic variables. Within each stratum, missing values were imputed using the hotdeck procedure.
14 For indicator variables (and categorical variables more generally), the hotdeck procedure has the advantage that the imputed values are constrained to be the original response choices "yes" and "no." The following variables had imputed values (number in parentheses): peak fl ow monitoring (1), goal setting (4), appropriateness of care (1), education (1), income (5).
Analysis
Performance of Participating vs Nonparticipating Sites
To fi nd out whether sites participating in both the BTS Collaborative and the evaluation performed better than sites participating in only the collaborative, we analyzed site ratings by the faculty. Site ratings ranged from 1 to 5 with 5 being best. We use a t test to compare the sites that participated with those that did not.
Surveys
We used 2-level hierarchical regression models with patients nested within sites. We used normal (Gaussian) regression for generic and asthma-specifi c HRQoL. We used logistic regression for satisfaction with communication. We used Poisson regressions to model the number of bed days and acute care service use. For improved interpretability, we report the effect of the intervention on the original scale: we give multivariate adjusted proportions, days, or scores. The multivariate adjusted proportions and counts were computed as the average predictions from the regression models of 2 slightly altered data sets: for one data set it was assumed that nobody received the intervention; for the other, that everyone received the intervention. 15 
Medical Records
To determine whether the BTS intervention improved processes of care, we compared changes in the processes of care between intervention and control groups (a differences-in-differences analysis). The preintervention period consisted of the 12 months before the intervention began (March 1, 1999, to March 1, 2000) . The postintervention 12-month period was deliberately delayed for 3 months (July 1, 2000, to June 30, 2001) to ensure that participating organizations had time to implement patient registries and other recommended changes. For all patients preintervention and postintervention scores were calculated for each of 9 quality indicators and for the overall process-of-care score.
The difference between before and after scores for both the intervention and control groups were calculated. Because quality improvements are naturally interpreted as differences rather than as ratios (a change from 10% to 40% in benefi cial process is preferred to a change from 1% to 4%, even though both changes represent the same ratio or odds), we used a linear probability model in the analysis. Adjusted differences between the intervention and control groups and the adjusted P values are reported for each individual indicator and for the summary process-of-care scores.
RESULTS
When we compared the sites participating in both the collaborative and the evaluation with the sites participating in only the collaborative, we found that participating sites had an average faculty rating of 3.81 and the nonparticipating sites had an average faculty rating of 3.92. The average difference in faculty ratings, -0.11, is not statistically signifi cant (P = .58) and is not large enough to be of practical relevance. There is no reason to believe that participating sites self-selected into the evaluation because they were high performers.
Changes Implemented
To assess changes made in the collaborative sites, we analyzed summary progress reports submitted in the 10th month of the collaborative year and the 2 monthly reports afterward. The analysis method was reported elsewhere. 16 On average, the sites made 36.2 changes to their systems (ranging from 27 to 51) during the course of the collaborative. All sites worked on guideline implementation, clinician and lay educator education, building a patient registry, use of information for care management, acquiring leadership support, and seeking or linking community resources. The areas with little or no implementation were a culture of practice team, availability of clinical guidelines to patients, a system of expert consultation support, and provision of fi nancial or organizational motivation to increase clinician and lay educator participation in quality improvement. During the collaborative period, 2 control sites also had active quality improvement programs or committees that addressed all chronic diseases, including asthma. The remaining control sites were not involved in any organized quality improvement activities. Some individual physicians implemented small changes independent of any offi cial quality improvement activity.
Participation and Demographic Characteristics
Twenty-six health care organizations accepted an open invitation to participate in the BTS Collaborative. Six organizations providing asthma care for adults and children agreed to provide a site for the adult evaluation, and 3 of these agreed to provide a control site. Survey data were obtained for 123 patients in 6 intervention sites and for 62 patients in 3 control sites. Medical record data were obtained for 109 patients in 3 intervention sites and for 76 patients in 2 control sites.
Demographic information by intervention or control group based on the survey is shown in Table  1 . The response rate was 76% (using the American Association for Public Opinion Research defi nition RR4). 17 Of those surveyed, 75 patients from the intervention group (61%) and 54 patients from the control group (92%) also agreed to have their medical record abstracted, as did an additional 34 patients from the intervention group and 22 patients from the control group who refused to participate in the survey interview. We therefore had medical records data for 109 patients in the intervention group and 76 patients in the control group. There were 3 sites (2 intervention and 1 control) that contributed survey data but not medical records (n = 32). Table 1 shows that patients in the control clinics had significantly more comorbidities than those in intervention clinics (2.1 vs 1.3, P = .007). The number of comorbidities ranged from 0 (43 patients, 23%) to 7 (2 patients, 1%). All other variables for the intervention and control groups in Table 1 are not signifi cantly different. Table 2 shows the postintervention scores (percentage of patients passing each indicator) and the change from the initial (preintervention) score. The control sites showed little or no improvement between the preintervention and postintervention periods. The largest improvement among control sites was a 7.1% increase in the percentage of patients being instructed in how to use metered-dose inhalers among patients who received inhaled medications. For 4 indicators the performance in the intervention clinics was signifi cantly higher than at the control clinics. The 4 improved indicators all refl ect patient self-management. The overall score at intervention sites also improved signifi cantly more (8.8%, P = .003) than the overall score at control sites. The intraclass cluster correlation for the overall score was 0.21. Other intraclass cluster correlations were as low as 0.02. Table 3 shows adjusted and unadjusted survey-based measures of process of care for both the control and intervention groups. The percentages shown are adjusted for covariates as described earlier. Patients in the intervention group were more likely than patients in the control group to attend educational sessions (20% vs 5%, respectively, P =.03). Having a written action plan, goal setting, peak fl ow monitoring, and use of long-term asthma control medications also increased in the intervention group (between 2% and 19%), but the differences were not statistically signifi cant. Asthmarelated knowledge was unchanged for the 2 groups.
Medical Records Results: Association Between the BTS Collaborative and Processes of Care
Survey Results: Association Between the Intervention on the BTS Collaborative and Processes of Care
Survey Results: Association Between the BTS Collaborative and Patient-Level Outcomes
A comparison between various outcomes measures of patients in the control groups and patients in the BTS Collaborative intervention is summarized in Table 4 . Patients receiving care in the BTS sites were significantly more likely to be satisfi ed with clinician and lay educator communication (62% vs 39%, P = .02). Satisfaction with clinician and lay educator communication was signifi cantly lower for the Asian, Pacifi c Islander, multiracial group (not shown). The use of acute care services was higher for patients receiving the intervention (1.72 vs 0.92 average visits); however, that difference did not reach statistical signifi cance (P = .08). Patients with more comorbid conditions used signifi cantly more acute care services.
Receiving care in a BTS clinic was not signifi cantly associated with HRQoL, asthma-specifi c HRQoL, or the number of bed days resulting from asthma-related illness. HRQoL was signifi cantly worse for older patients and for those with mild, moderate, or severe persistent asthma. High income was associated with signifi cantly higher HRQoL. More comorbid conditions and having mild, moderate, or severe persistent asthma were associated with worse asthma-specifi c HRQoL. Moderate to severe persistent asthma and more comorbid conditions were associated with a signifi cantly more bed days. Patients with higher income and patients with less education had signifi cantly fewer bed days.
DISCUSSION
In a collaborative intervention, small teams from health organizations are encouraged to transform their larger organizations by implementing ideas from a menu of possible changes. In the real-world setting of our evaluation, these small teams must contend with daily onthe-job crises and organizational inertia. A recent study of quality improvement collaboratives across many sites for patients infected with human immunodefi ciency virus showed a statistically insignifi cant improvement in process of care. 18 An accompanying editorial noted that there was general enthusiasm for Breakthrough Series initiatives, but there was scarce evidence in the literature to support that enthusiasm. 19 Nevertheless, this evaluation study indicates that participants in the BTS Collaborative successfully improved process of care for several aspects of patient self-management. Evidence from the chart review of greater improvement in the participating sites was corroborated by patient reports on attending educational class(es) and self-management practices. Because of their previously established commitment to improved health outcomes in asthmatics, the faculty stressed these self-management strategies during the 3 BTS Collaborative learning sessions.
There is evidence all areas of process improvement-attending educational sessions, having a written action plan, goal setting, and peak fl ow monitoring-can improve clinical outcome measures. Ford found that patients randomized to an intervention consisting of 3 educational sessions signifi cantly reduced the number of visits to an emergency department. 20 For an educational intervention consisting of 6 monthly sessions, deOliveira et al found that patients who received the intervention had signifi cantly fewer emergency department visits and signifi cantly better quality of life. 21 Although we found that the intervention increased attendance at educational sessions, the intervention did not translate into a better quality of life, possibly because we had no information about the actual number of educational sessions attended.
Gibson found that optimal self-management, when it included a written action plan, led to a signifi cant reduction in hospitalizations for asthma-related illness. 22 Our study does not fi nd such a reduction, possibly because patients who manage their asthma better are more aware of their exact physical condition. Greater awareness may lead patients to perceive a greater need of acute care services. A recent study of quality of care in the United States found underuse to be more a problem than overuse. 10 A written action plan was linked with improved health outcomes in the meta-analysis by Bodenheimer et al. 23 When Toelle and Ram 24 conducted a meta-analysis of the few randomized trials on the effect of a written action plan on clinical outcomes, however, they concluded that "available trials are too small and the results too inconsistent" to yield any defi nite conclusions on clinical outcomes. Finally, in an intervention that emphasized peak fl ow monitoring, Lahdensuo et al found that patients with the intervention had signifi cantly fewer direct medical costs, fewer unscheduled outpatient visits, and fewer work days missed because of asthma-related illness, as well as a signifi cantly better quality of life. 25, 26 Overall, our fi ndings on process of care are similar to the fi ndings obtained for the pediatric population in the same study. 27 For the pediatric population more effects were signifi cant because the sample sizes were larger.
The BTS Collaborative increased patient satisfaction with clinician and lay educator communication. Satisfaction is a more proximate outcome than HRQoL or asthma-specifi c HRQoL, and it was easier and quicker to affect than more distal outcomes, especially because the BTS faculty emphasized improved physician-patient communication through goal setting, having a written action plan, and peak fl ow monitoring. The literature supports the link between improved physician-patient communication and increased satisfaction with care. 21, [28] [29] [30] [31] [32] The BTS Collaborative did not have a signifi cant effect on other health outcome measures in our study. The lack of signifi cance does not appear to be due to insensitive measures, as these outcomes were consistently associated with worse asthma and comorbidities. The lack of measured infl uence of the BTS Collaborative on these outcomes might be explained, however, by the brief follow-up period in our study. Patients were interviewed during the 9 months after the collaborative had ended. Whereas processes of care had clearly improved, the infl uence on health-related outcomes might not have been able to be detected for several months after the improved processes were implemented. It is also possible that the control population had better HRQoL or asthma-specifi c HRQoL at baseline compared with the interven- Number of days in bed due to asthma-related illness 2 2 0 .77 * Scale between 0 and 10 where 0 is best (no impact) and 10 is worst (large impact). † Signifi cant at P <.05.
tion population. If such were the case, improvements in outcomes for the intervention group would not be detected, as we were able to measure outcomes only during the postintervention phase of the collaborative. Other studies also have reported lack of evidence that an asthma intervention has an effect on health outcomes. A recent meta-analysis related to the Chronic Care Model reviewed 27 articles about asthma. The study found evidence that the Chronic Care Model reduced emergency department use but did not fi nd improved quality of life. 33 The effect of the intervention on some survey-based measurements of process of care was large but not statistically signifi cant. The lack of statistical signifi cance was due to insuffi cient power. To detect an effect of the magnitude indicated in Table 3 , we had 48% power for written action plan and 24% power for peak fl ow monitoring. With the exception of satisfaction with clinician and lay educator communication, the surveybased estimated effects on outcome measures were small or none. The study was not underpowered for the continuous quality-of-life measures: the study had 80% power to detect an improvement in HRQoL of 4.4 or an improvement in asthma-specifi c HRQoL of 1.0.
Although the survey did include a control group, the survey analysis is limited by the lack of preintervention measurements. This limitation is mitigated through the availability medical records with preintervention and postintervention data. These data confi rm survey results and show that there is no secular trend. We were not able to obtain preintervention measurements for the survey; dealing with the local institutional review boards (IRBs) took on average 14 months, far longer than anticipated. By the time we had resolved all issues and obtained consent to contact patients, the intervention was already in place, thus preventing us from taking any preintervention measurements. 8 This BTS Collaborative implementing the Chronic Care Model to improve asthma care had a positive effect on patient self-management practices that have previously been linked to improved health outcomes. The BTS Collaborative signifi cantly improved satisfaction with clinician and lay educator communication. Studies that are large enough to measure gains in all health outcomes from quality improvement may have to be conducted in large health care systems. 
